Traws Pharma, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Traws Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q3 2024.
Traws Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.54M, a 67.7% decline year-over-year.
Traws Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$142M, a 556% decline year-over-year.
Traws Pharma, Inc. annual Operating Income (Loss) for 2023 was -$20.3M, a 3.42% decline from 2022.
Traws Pharma, Inc. annual Operating Income (Loss) for 2022 was -$19.6M, a 19% decline from 2021.
Traws Pharma, Inc. annual Operating Income (Loss) for 2021 was -$16.5M, a 34% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$142M	-$8.54M	-$3.45M	-67.7%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	-$138M	-$123M	-$119M	-2576%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-15
Q1 2024	-$19.4M	-$5.21M	+$925K	+15.1%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$20.3M	-$4.46M	+$1.27M	+22.2%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-01
Q3 2023	-$21.6M	-$5.09M	+$552K	+9.79%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	-$22.1M	-$4.61M	-$490K	-11.9%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-15
Q1 2023	-$21.6M	-$6.14M	-$2.01M	-48.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	-$19.6M	-$5.73M	-$1.97M	-52.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-01
Q3 2022	-$17.7M	-$5.64M	-$1.65M	-41.4%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	-$16M	-$4.12M	+$525K	+11.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	-$16.5M	-$4.13M	-$34K	-0.83%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$16.5M	-$3.76M	+$2.49M	+39.8%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-30
Q3 2021	-$19M	-$3.99M	+$2.28M	+36.4%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$21.3M	-$4.65M	+$2.69M	+36.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-15
Q1 2021	-$24M	-$4.1M	+$1.03M	+20%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-13
Q4 2020	-$25M	-$6.26M	-$528K	-9.22%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-21
Q3 2020	-$24.5M	-$6.27M	-$1.18M	-23.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$23.3M	-$7.34M	-$3.71M	-102%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	-$19.6M	-$5.13M	+$2.12M	+29.2%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$21.7M	-$5.73M	+$420K	+6.83%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-18
Q3 2019	-$22.1M	-$5.1M	+$496K	+8.87%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16
Q2 2019	-$22.6M	-$3.63M	+$2.01M	+35.6%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-12
Q1 2019	-$24.6M	-$7.24M	-$1.34M	-22.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-15
Q4 2018	-$23.3M	-$6.15M	-$30K	-0.49%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-27
Q3 2018	-$23.3M	-$5.59M	+$1.17M	+17.2%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$24.4M	-$5.64M	+$430K	+7.09%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018	-$24.8M	-$5.9M	+$890K	+13.1%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-15
Q4 2017	-$25.7M	-$6.12M	+$352K	+5.44%	Oct 1, 2017	Dec 31, 2017	10-K	2019-04-01
Q3 2017	-$26.1M	-$6.76M	-$2.44M	-56.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-14
Q2 2017	-$23.6M	-$6.07M	-$670K	-12.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-14
Q1 2017	-$23M	-$6.79M	+$728K	+9.68%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	-$23.7M	-$6.47M	-$9.68M	-301%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-16
Q3 2016	-$14M	-$4.32M	+$1.56M	+26.6%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-09
Q2 2016	-$15.6M	-$5.4M	+$3.56M	+39.7%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	-$19.1M	-$7.52M	+$4.83M	+39.1%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-15
Q4 2015	-$24M	$3.21M	+$16.6M		Oct 1, 2015	Dec 31, 2015	10-K	2017-03-29
Q3 2015	-$40.5M	-$5.88M	+$9.01M	+60.5%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-14
Q2 2015	-$49.6M	-$8.96M	+$7.81M	+46.6%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-15
Q1 2015	-$57.4M	-$12.3M	+$6.38M	+34.1%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-11
Q4 2014	-$63.7M	-$13.4M	+$1.2M	+8.24%	Oct 1, 2014	Dec 31, 2014	10-K	2015-03-30
Q3 2014	-$64.9M	-$14.9M	+$5.22M	+25.9%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014	-$70.2M	-$16.8M	-$4.19M	-33.3%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-13
Q1 2014	-$66M	-$18.7M	-$3.75M	-25%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-15
Q4 2013	-$62.2M	-$14.6M	-$4.25M	-41.3%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-30
Q3 2013	-$58M	-$20.1M	-$27M	-391%	Jul 1, 2013	Sep 30, 2013	10-K	2015-03-30
Q2 2013	-$30.9M	-$12.6M	-$4.39M	-53.6%	Apr 1, 2013	Jun 30, 2013	10-K	2015-03-30
Q1 2013	-$26.6M	-$15M	-$4.28M	-39.9%	Jan 1, 2013	Mar 31, 2013	10-K	2015-03-30
Q4 2012	-$22.3M	-$10.3M			Oct 1, 2012	Dec 31, 2012	10-K	2014-03-20
Q3 2012		$6.92M			Jul 1, 2012	Sep 30, 2012	10-K	2014-03-20
Q2 2012		-$8.18M			Apr 1, 2012	Jun 30, 2012	10-K	2014-03-20
Q1 2012		-$10.7M			Jan 1, 2012	Mar 31, 2012	10-K	2014-03-20

* An asterisk sign (*) next to the value indicates that the value is likely invalid.